GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Boston Scientific Corp (WBO:BSXC) » Definitions » Margin of Safety % (DCF FCF Based)

Boston Scientific (WBO:BSXC) Margin of Safety % (DCF FCF Based) : -264.92% (As of Dec. 11, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Boston Scientific Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

As of today (2024-12-11), Boston Scientific's Predictability Rank is 3-Stars. Boston Scientific's intrinsic value calculated from the Discounted FCF model is €32.64 and current share price is €85.50. Consequently,

Boston Scientific's Margin of Safety % (DCF FCF Based) using Discounted FCF model is -264.92%.

Competitive Comparison of Boston Scientific's Margin of Safety % (DCF FCF Based)

For the Medical Devices subindustry, Boston Scientific's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Boston Scientific's Margin of Safety % (DCF FCF Based) Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Boston Scientific's Margin of Safety % (DCF FCF Based) falls into.


Boston Scientific Margin of Safety % (DCF FCF Based) Calculation

Boston Scientific's Margin of Safety % (DCF FCF Based) for today is calculated as

Margin of Safety % (DCF FCF Based)=(Intrinsic Value: DCF (FCF Based)-Current Price)/Intrinsic Value: DCF (FCF Based)
=(23.43-85.50)/23.43
=-264.92 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted FCF model with default parameters. The calculation method is the same as Discounted Earnings model except free cash flow are used in the calculation instead of earnings per share.

Boston Scientific Margin of Safety % (DCF FCF Based) Related Terms

Thank you for viewing the detailed overview of Boston Scientific's Margin of Safety % (DCF FCF Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Boston Scientific Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Boston Scientific Corp (WBO:BSXC) » Definitions » Margin of Safety % (DCF FCF Based)
Comparable Companies
SYK MDT ABT EW DXCM ZBH STE PODD GMED PEN XTER:SHL SZSE:300760 XAMS:PHIA XSWX:SOON SHSE:688271 ASX:COH LSE:SN. BIO MASI BRKR
Traded in Other Exchanges
BSX:USA BSX:Mexico 1BSX:Italy 0HOY:UK BSX:Germany BSX:Germany BSX:Germany B1SX34:Brazil
Address
300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234
Website
https://www.bostonscientific.com
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

Boston Scientific Headlines

No Headlines